Avidity Partners Management LP - Significant Ownership

Signature - Title
Delmer Dee Raibourn III - Chief Compliance Officer
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Avidity Partners Management LP.

Significant Ownership of Avidity Partners Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value 9.9% $61.3M 3.38M Avidity Partners Management LP Mar 17, 2025
IMUX IMMUNIC, INC. Common Stock, par value $0.0001 9.9% $9.43M 9.02M Avidity Partners Management LP Dec 31, 2024
CNTX Context Therapeutics Inc. $0.001 par value per share 9.9% $6.14M 7.78M Avidity Private Master Fund I LP Dec 31, 2024
SCYX SCYNEXIS INC Common Stock, par value $0.001 per share 9.9% $3.91M 4.21M Avidity Master Fund LP Dec 31, 2024
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value 7.6% $123K 2.05M Avidity Partners Management LP Dec 31, 2024
KZR Kezar Life Sciences, Inc. Common Stock, par value $0.001 per share 6.9% $387K 503K Avidity Partners Management LP Dec 31, 2024
CATX Perspective Therapeutics, Inc. Common Stock, $0.001 par value 4.2% $6.05M 2.84M Avidity Partners Management LP Dec 31, 2024

Schedules 13D/G Reported by Avidity Partners Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.